Catalyst Wire Dossier Catalyst Wire Dossier

LENVIMA

lenvatinib · Eisai Inc.
Drug timelines are a Plus or Pro feature.

200 regulatory and trial events tracked for LENVIMA, covering 2015-02-13 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC [NA]

See pricing